Ellicott City, MD, United States of America

Yuping Mei

This inventor holds 1 USPTO granted patent. Top assignee: University System of Maryland. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuping Mei. Retrieved from https://idiyas.com/inventor/yuping-mei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yuping Mei in RNA Research

Introduction

Yuping Mei is an accomplished inventor based in Ellicott City, MD (US). He has made significant contributions to the field of molecular biology, particularly in the area of regulatory RNAs. His work focuses on the development of innovative solutions that enhance our understanding of gene regulation.

Latest Patents

Yuping Mei holds a patent for "Short non-coding protein regulatory RNAs (sprRNAs) and methods of use." This invention provides isolated nucleic acid molecules comprising short non-coding protein regulatory RNAs (sprRNA), along with their variants, fragments, and inhibitors. The patent also includes compositions and methods for utilizing these molecules, which have potential applications in various biological and therapeutic contexts.

Career Highlights

Yuping Mei is affiliated with the University System of Maryland, where he continues to advance research in RNA biology. His academic and research endeavors have positioned him as a key figure in the exploration of non-coding RNAs and their regulatory roles in cellular processes.

Collaborations

Yuping Mei collaborates with Li Mao, a fellow researcher who contributes to the ongoing projects in their field. Their partnership exemplifies the collaborative spirit of scientific research, fostering innovation and discovery.

Conclusion

Yuping Mei's work in the realm of short non-coding protein regulatory RNAs represents a significant advancement in molecular biology. His contributions not only enhance our understanding of gene regulation but also pave the way for future innovations in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…